Focused Wealth Management’s CASI Pharmaceuticals CASI Stock Holding History

Focused Wealth Management’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5	Closed	–	–	718
2019 Q3	$0	Hold	5	–	–	﹤0.01%	705
2019 Q2	$0	Hold	5	–	–	﹤0.01%	734
2019 Q1	$0	Hold	5	–	–	﹤0.01%	702
2018 Q4	$0	Hold	5	–	–	﹤0.01%	689
2018 Q3	$0	Hold	5	–	–	﹤0.01%	659
2018 Q2	$0	Hold	5	–	–	﹤0.01%	673
2018 Q1	$0	Hold	5	–	–	﹤0.01%	696
2017 Q4	$0	Hold	5	–	–	﹤0.01%	685
2017 Q3	$0	Hold	5	–	–	﹤0.01%	655
2017 Q2	$0	Hold	5	–	–	﹤0.01%	701
2017 Q1	$0	Hold	5	–	–	﹤0.01%	691
2016 Q4	$0	Hold	5	–	–	﹤0.01%	689
2016 Q3	$0	Hold	5	–	–	﹤0.01%	661
2016 Q2	$0	Hold	5	–	–	﹤0.01%	669
2016 Q1	$0	Hold	5	–	–	﹤0.01%	659
2015 Q4	$0	Hold	5	–	–	﹤0.01%	676
2015 Q3	$0	Hold	5	–	–	﹤0.01%	680
2015 Q2	$0	Hold	5	–	–	﹤0.01%	664
2015 Q1	$0	Hold	5	–	–	﹤0.01%	675
2014 Q4	$0	Hold	5	–	–	﹤0.01%	663
2014 Q3	$0	Buy	+5	New	+$89	﹤0.01%	688
2014 Q2	–	Sell	-5	Closed	–	–	668
2014 Q1	$0	Hold	5	–	–	﹤0.01%	630
2013 Q4	$0	Buy	+5	New	+$85	﹤0.01%	620

Other funds holding CASI

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Focused Wealth Management's CASI Position: Q4 2019 in Review

Focused Wealth Management sold out of CASI Pharmaceuticals (CASI) in Q4 2019, closing a stake of 5 shares.

Focused Wealth Management first reported a position in CASI in Q4 2013 and held it in 23 quarters. The position peaked at $0 in Q3 2019. 53 funds tracked by Wall St. Rank hold CASI as of Q4 2019.

Focused Wealth Management reported no remaining CASI Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Focused Wealth Management sold 5 CASI Pharmaceuticals shares in Q4 2019.
Focused Wealth Management first reported a position in CASI Pharmaceuticals in Q4 2013 and held it in 23 quarters.
Focused Wealth Management's CASI Pharmaceuticals position peaked at $0 in Q3 2019.
53 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2019.

Based on Focused Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.